|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Shek FH, Fatima S and Lee NP: Implications
of the use of eukaryotic tanslation initiation factor 5A (eIF5A)
for prognosis and treatment of hepatocellular carcinoma. Int J
Hepatol. 2012:7609282012.PubMed/NCBI
|
|
3.
|
Hagen RM, Chedea VS, Mintoff CP, Bowler E,
Morse HR and Ladomery MR: Epigallocatechin-3-gallate promotes
apoptosis and expression of the caspase 9a splice variant in PC3
prostate cancer cells. Int J Oncol. 43:194–200. 2013.PubMed/NCBI
|
|
4.
|
Li JJ, Gu QH, Li M, Yang HP, Cao LM and Hu
CP: Role of Ku70 and Bax in epigallocatechin-3-gallate-induced
apoptosis of A549 cells in vivo. Oncol Lett. 5:101–106.
2013.PubMed/NCBI
|
|
5.
|
Liu D, Li P, Song S, et al: Pro-apoptotic
effect of epigallo-cate-chin-3-gallate on B lymphocytes through
regulating BAFF/PI3K/Akt/mTOR signaling in rats with
collagen-induced arthritis. Eur J Pharmacol. 690:214–225. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Zhang G, Miura Y and Yagasaki K:
Suppression of adhesion and invasion of hepatoma cells in culture
by tea compounds through antioxidative activity. Cancer Lett.
159:169–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Shankar S, Ganapathy S, Hingorani SR and
Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and
metastasis of pancreatic cancer. Front Biosci. 13:440–452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Shankar S, Marsh L and Srivastava RK: EGCG
inhibits growth of human pancreatic tumors orthotopically implanted
in Balb C nude mice through modulation of FKHRL1/FOXO3a and
neuropilin. Mol Cell Biochem. 372:83–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Inaba H, Nagaoka Y, Kushima Y, et al:
Comparative examination of anti-proliferative activities of
(-)-epigallocatechin gallate and (--)-epigallocatechin against
HCT116 colorectal carcinoma cells. Biol Pharm Bull. 31:79–84. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Li ZG, Shimada Y, Sato F, et al: Promotion
effects of hot water on N-nitrosomethylbenzylamine-induced
esophageal tumorigenesis in F344 rats. Oncol Rep. 10:421–426.
2003.PubMed/NCBI
|
|
11.
|
Kushima Y, Iida K, Nagaoka Y, et al:
Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin
gallate against heregulin beta1-induced migration/invasion of the
MCF-7 breast carcinoma cell line. Biol Pharm Bull. 32:899–904.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY
and Way TD: EGCG inhibits protein synthesis, lipogenesis, and cell
cycle progression through activation of AMPK in p53 positive and
negative human hepatoma cells. Mol Nutr Food Res. 53:1156–1165.
2009. View Article : Google Scholar
|
|
13.
|
Kim H and Sakamoto K: (-)-Epigallocatechin
gallate suppresses adipocyte differentiation through the MEK/ERK
and PI3K/Akt pathways. Cell Biol Int. 36:147–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Qin J, Xie LP, Zheng XY, et al: A
component of green tea, (-)-epigallocatechin-3-gallate, promotes
apoptosis in T24 human bladder cancer cells via modulation of the
PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res
Commun. 354:852–857. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Shirakami Y, Shimizu M, Adachi S, et al:
(-)-Epigallocatechin gallate suppresses the growth of human
hepatocellular carcinoma cells by inhibiting activation of the
vascular endothelial growth factor-vascular endothelial growth
factor receptor axis. Cancer Sci. 100:1957–1962. 2009. View Article : Google Scholar
|
|
16.
|
Tsang WP and Kwok TT: Epigallocatechin
gallate up-regulation of miR-16 and induction of apoptosis in human
cancer cells. J Nutr Biochem. 21:140–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Uesato S, Kitagawa Y, Kamishimoto M,
Kumagai A, Hori H and Nagasawa H: Inhibition of green tea catechins
against the growth of cancerous human colon and hepatic epithelial
cells. Cancer Lett. 170:41–44. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Abou El Naga RN, Azab SS, El-Demerdash E,
Shaarawy S, El-Merzabani M and Ammar el SM: Sensitization of
TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2
cells by phytochemicals. Life Sci. 92:555–561. 2013.PubMed/NCBI
|
|
19.
|
Nishikawa T, Nakajima T, Moriguchi M, et
al: A green tea polyphenol, epigalocatechin-3-gallate, induces
apoptosis of human hepatocellular carcinoma, possibly through
inhibition of Bcl-2 family proteins. J Hepatol. 44:1074–1082. 2006.
View Article : Google Scholar
|
|
20.
|
Bu X, Jia F, Wang W, Guo X, Wu M and Wei
L: Coupled down-regulation of mTOR and telomerase activity during
fluorouracil-induced apoptosis of hepatocarcinoma cells. BMC
Cancer. 7:2082007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Tang C, Lu YH, Xie JH, et al:
Downregulation of survivin and activation of caspase-3 through the
PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Anticancer Drugs. 20:249–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zhang Q, Tang X, Lu Q, Zhang Z, Rao J and
Le AD: Green tea extract and (-)-epigallocatechin-3-gallate inhibit
hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF
expression in human cervical carcinoma and hepatoma cells. Mol
Cancer Ther. 5:1227–1238. 2006. View Article : Google Scholar
|
|
23.
|
Zhang G, Wang Y, Zhang Y, et al:
Anti-cancer activities of tea epigallocatechin-3-gallate in breast
cancer patients under radiotherapy. Curr Mol Med. 12:163–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Park SB, Bae JW, Kim JM, Lee SG and Han M:
Antiproliferative and apoptotic effect of
epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex
steroid receptor downregulation. Int J Mol Med. 30:1211–1218.
2012.PubMed/NCBI
|
|
25.
|
De Amicis F, Perri A, Vizza D, et al:
Epigallocatechin gallate inhibits growth and
epithelial-to-mesenchymal transition in human thyroid carcinoma
cell lines. J Cell Physiol. 228:2054–2062. 2013.PubMed/NCBI
|
|
26.
|
Dang TP: Notch, apoptosis and cancer. Adv
Exp Med Biol. 727:199–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Datta SR, Brunet A and Greenberg ME:
Cellular survival: a play in three Akts. Genes Dev. 13:2905–2927.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Roos WP and Kaina B: DNA damage-induced
cell death: from specific DNA lesions to the DNA damage response
and apoptosis. Cancer Lett. 332:237–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Shimizu M, Shirakami Y, Sakai H, et al:
EGCG inhibits activation of the insulin-like growth factor
(IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.
Cancer Lett. 262:10–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Kaufmann R, Henklein P, Henklein P and
Settmacher U: Green tea polyphenol epigallocatechin-3-gallate
inhibits thrombin-induced hepatocellular carcinoma cell invasion
and p42/p44-MAPKinase activation. Oncol Rep. 21:1261–1267. 2009.
View Article : Google Scholar
|
|
31.
|
Chen XL, Wang Q, Cao LQ, et al:
Epigallocatechin-3-gallate induces apoptosis in human
hepatocellular carcinoma cells. Zhonghua Yi Xue Za Zhi.
88:2524–2528. 2008.(In Chinese).
|
|
32.
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Comparative effects of EGCG, green tea and a
nutrient mixture on the patterns of MMP-2 and MMP-9 expression in
cancer cell lines. Oncol Rep. 24:747–757. 2010.PubMed/NCBI
|
|
33.
|
Zhang Y, Owusu L, Duan W, et al:
Anti-metastatic and differential effects on protein expression of
epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma
cells. Int J Mol Med. 32:959–964. 2013.PubMed/NCBI
|
